Leal Therapeutics Appoints Executives, Updates Business
13 Apr 2026 //
PR NEWSWIRE
Leal Raises $30M Series A for Neuro-Metabolic Therapies
27 Aug 2025 //
PR NEWSWIRE
Leal Therapeutics Secures $45M for Neurodegenerative Disorders
30 Oct 2024 //
PR NEWSWIRE

Market Place
Sourcing Support